Login / Signup

Tocilizumab's efficacy in patients with Coronavirus Disease 2019 (COVID-19) is determined by the presence of cytokine storm.

Ioannis AndrianopoulosAthanasios PapathanasiouGeorgios PapathanakosAristeidis ChaidosVasilios Koulouras
Published in: Journal of medical virology (2020)
Keyphrases
  • coronavirus disease
  • rheumatoid arthritis
  • respiratory syndrome coronavirus
  • juvenile idiopathic arthritis
  • rheumatoid arthritis patients
  • sars cov